An approach that could reduce the chances of drugs failing during the later stages of clinical trials has been demonstrated by a collaboration between the University of Cambridge and pharmaceutical company GlaxoSmithKline (GSK). The technique involves identifying genetic variants that mimic the action of a drug on its intended target and then checking in large [...]
Martindale Pharma, the UK-based leading international specialty pharma company, has announced that it has signed a multi-year exclusive manufacturing agreement with Burton Hospitals NHS Foundation Trust. Under the terms of the agreement, Burton Hospitals NHS Foundation Trust will supply a number of Martindale Pharma’s key specialty generic products, including Bismuth Iodoform Paraffin Paste (BIPP) and [...]
Mylan NV has announced its financial results for the quarter ended 31st March, 2016. Financial Highlights Total revenues of $2.19 billion; up 19 per cent on a constant currency basis compared to the prior year period (up 17 per cent on a US. GAAP basis) Generics segment third party net sales of $1.93 billion; up 19 [...]
Mylan NV has announced the US launch of Metoprolol Tartrate Tablets USP, 37.5mg and 75mg, which is the generic version of Novartis' Lopressor® Tablets. These strengths are the first and only available intermediate dosage strengths between the existing Metoprolol Tartrate Tablets USP strengths of 25mg, 50mg and 100mg. Mylan currently is the only manufacturer that [...]
Medicines for Europe Better access. Better health is the new name of EGA. The repositioning of the association as Medicines for Europe aims to drive greater healthcare efficiency through better health outcomes while providing solutions for the sustainability of European healthcare systems facing increased demographic demands on healthcare services. ‘Medicines for Europe Better access. Better health [...]
Mylan N.V. has announced that Mylan CEO Heather Bresch has been elected to serve as chair of the Generic Pharmaceutical Association's (GPhA) board of directors. GPhA is an association that represents the world's leading generic drug manufacturers and suppliers and plays a critical role in tackling key issues affecting the generics industry and shaping policies [...]
